| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TLXTelix Pharmaceuticals Limited | 2.49B | 7.43 | 53.07 | 55.85% | 3.98% | 15.63% | 0.36% | 1.02 |
| EXELExelixis, Inc. | 12.18B | 45.44 | 25.82 | 18.49% | 29.63% | 31.37% | 5.2% | 0.09 |
| BBOTBridgeBio Oncology Therapeutics Inc. | 919.87M | 11.50 | 25 | -25.73% | ||||
| INBXInhibrx Biosciences, Inc. | 1.04B | 71.80 | 0.62 | -88.89% | -110.78% | -421.09% | 0.06 | |
| NUVBNuvation Bio Inc. | 2.1B | 6.14 | -2.91 | -8.13% | -66.74% | 0.02 | ||
| RLAYRelay Therapeutics, Inc. | 1.32B | 7.63 | -3.23 | -60.83% | -26.71% | -48.97% | 0.06 | |
| ORICORIC Pharmaceuticals, Inc. | 1.12B | 11.52 | -6.30 | -33.24% | 0.01 | |||
| ZLABZai Lab Limited | 2.09B | 18.82 | -7.24 | 49.59% | -46.83% | -27.21% | 0.18 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 9.68M | 10.05M | 1.5M | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | 0.04% | -0.85% | -1% | - | - |
| Cost of Goods Sold | 0 | 25K | 48K | 49K | 4.56M | 4.93M | 0 | 0 | 427K | 0 |
| COGS % of Revenue | - | - | - | - | 0.47% | 0.49% | - | - | - | - |
| Gross Profit | 0 | -25K | -48K | -49K | 5.12M | 5.12M | 1.5M | 0 | -427K | 0 |
| Gross Margin % | - | - | - | - | 0.53% | 0.51% | 1% | - | - | - |
| Gross Profit Growth % | - | - | -0.92% | -0.02% | 105.57% | -0% | -0.71% | -1% | - | 1% |
| Operating Expenses | 21.09M | 27.52M | 32.35M | 30M | 8.6M | 8.57M | 42.93M | 56.76M | 86.61M | 70.06M |
| OpEx % of Revenue | - | - | - | - | 0.89% | 0.85% | 28.62% | - | - | - |
| Selling, General & Admin | 5.72M | 4.23M | 9.85M | 8.92M | 7.44M | 7.02M | 10.77M | 11.8M | 13.38M | 12.85M |
| SG&A % of Revenue | - | - | - | - | 0.77% | 0.7% | 7.18% | - | - | - |
| Research & Development | 15.37M | 23.29M | 22.5M | 21.07M | 1.13M | 1.43M | 32.16M | 44.97M | 73.23M | 57.21M |
| R&D % of Revenue | - | - | - | - | 0.12% | 0.14% | 21.44% | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 34K | 118K | 0 | 0 | 0 | 0 |
| Operating Income | -21.09M | -27.52M | -32.35M | -30.75M | -3.48M | -3.45M | -41.43M | -56.76M | -87.04M | -70.06M |
| Operating Margin % | - | - | - | - | -0.36% | -0.34% | -27.62% | - | - | - |
| Operating Income Growth % | -0.01% | -0.3% | -0.18% | 0.05% | 0.89% | 0.01% | -11.02% | -0.37% | -0.53% | 0.2% |
| EBITDA | -20.61M | -27.5M | -32.3M | -30.7M | -3.27M | -3.24M | -41.4M | -56.75M | -86.61M | -70.05M |
| EBITDA Margin % | - | - | - | - | -0.34% | -0.32% | -27.6% | - | - | - |
| EBITDA Growth % | -0.02% | -0.33% | -0.17% | 0.05% | 0.89% | 0.01% | -11.79% | -0.37% | -0.53% | 0.19% |
| D&A (Non-Cash Add-back) | 474K | 25K | 48K | 49K | 206K | 210K | 29K | 16K | 427K | 5K |
| EBIT | -11.92M | -24.4M | -29.76M | -23.1M | -3.48M | -3.44M | -40.57M | -54.4M | -81.41M | -70.06M |
| Net Interest Income | 138K | -1.23M | 49K | 428K | 30K | 54K | -32K | 871K | 4.03M | 3.13M |
| Interest Income | 156K | 2K | 170K | 447K | 313K | 93K | 9K | 925K | 4.03M | 3.13M |
| Interest Expense | 18K | 1.23M | 121K | 19K | 23K | 39K | 41K | 54K | 0 | 0 |
| Other Income/Expense | 9.04M | 1.89M | 2.47M | 7.63M | 30K | 59K | 815K | 2.31M | 5.63M | 3.09M |
| Pretax Income | -20.95M | -25.63M | -29.88M | -23.12M | -3.45M | -3.39M | -40.61M | -54.45M | -81.41M | -66.97M |
| Pretax Margin % | - | - | - | - | -0.36% | -0.34% | -27.07% | - | - | - |
| Income Tax | 152K | 0 | -157K | 20K | 0 | 0 | -24K | 147K | 0 | 585K |
| Effective Tax Rate % | 1.01% | 1% | 0.99% | 1% | 1% | 1% | 1% | 1% | 1% | 1.01% |
| Net Income | -21.1M | -25.63M | -29.73M | -23.14M | -3.45M | -3.39M | -40.59M | -54.6M | -81.41M | -67.56M |
| Net Margin % | - | - | - | - | -0.36% | -0.34% | -27.06% | - | - | - |
| Net Income Growth % | 0.17% | -0.21% | -0.16% | 0.22% | 0.85% | 0.02% | -10.98% | -0.35% | -0.49% | 0.17% |
| Net Income (Continuing) | -12.05M | -25.63M | -29.73M | -23.14M | -3.45M | -3.39M | -40.59M | -54.6M | -81.41M | -67.56M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -12.37 | -27.29 | -32.35 | -16.05 | -14.57 | -4.64 | -4.73 | -4.82 | -3.98 | -1.81 |
| EPS Growth % | 0.42% | -1.21% | -0.19% | 0.5% | 0.09% | 0.68% | -0.02% | -0.02% | 0.17% | 0.55% |
| EPS (Basic) | -12.37 | -27.29 | -32.45 | -16.36 | -14.57 | -4.64 | -4.73 | -4.82 | -3.98 | -1.81 |
| Diluted Shares Outstanding | 1.71M | 939.24K | 918.86K | 1.44M | 2.26M | 5.93M | 8.58M | 11.32M | 20.45M | 37.55M |
| Basic Shares Outstanding | 1.71M | 939.24K | 916.18K | 1.41M | 2.26M | 5.93M | 8.58M | 11.32M | 20.45M | 37.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 27.92M | 4.03M | 27.66M | 17.32M | 5.51M | 67.3M | 116.87M | 53.22M | 71.6M | 48.04M |
| Cash & Short-Term Investments | 27.57M | 793K | 25.74M | 16.28M | 2.39M | 63.83M | 114.92M | 43.76M | 70.64M | 47.25M |
| Cash Only | 20.97M | 793K | 25.74M | 16.28M | 2.39M | 63.83M | 114.92M | 20.99M | 70.64M | 47.25M |
| Short-Term Investments | 6.61M | 0 | 0 | 0 | 0 | 0 | 0 | 22.76M | 0 | 0 |
| Accounts Receivable | 0 | 3.17M | 1.74M | 836K | 2.04M | 2.01M | 1.19M | 1.36M | 771K | 704K |
| Days Sales Outstanding | - | - | - | - | 77.07 | 73.09 | 289.32 | - | - | - |
| Inventory | 0 | 30K | 0 | 0 | 645K | 980K | 0 | 1.4M | 0 | 0 |
| Days Inventory Outstanding | - | 438 | - | - | 51.67 | 72.53 | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 58K | 59K | 0 | 6.26M | 183K | 86K |
| Total Non-Current Assets | 232K | 2.43M | 1.4M | 1.75M | 3.19M | 3.11M | 1.04M | 4.88M | 1.23M | 1.08M |
| Property, Plant & Equipment | 232K | 119K | 135K | 86K | 2.74M | 2.73M | 495K | 371K | 262K | 262K |
| Fixed Asset Turnover | - | - | - | - | 3.54x | 3.69x | 3.03x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 138K | 130K | 0 | 25K | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 150K | 0 | 0 |
| Other Non-Current Assets | 0 | 2.31M | 1.11M | 1.54M | 318K | 258K | 383K | 4.33M | 966K | 823K |
| Total Assets | 28.15M | 6.46M | 29.06M | 19.07M | 8.7M | 70.42M | 117.91M | 58.09M | 72.83M | 49.12M |
| Asset Turnover | - | - | - | - | 1.11x | 0.14x | 0.01x | - | - | - |
| Asset Growth % | -0.42% | -0.77% | 3.5% | -0.34% | -0.54% | 7.09% | 0.67% | -0.51% | 0.25% | -0.33% |
| Total Current Liabilities | 1.28M | 36.16M | 6.08M | 6.45M | 1.57M | 1.8M | 9.99M | 3.12M | 12.68M | 14.08M |
| Accounts Payable | 2.05M | 3.23M | 2.62M | 3.58M | 654K | 730K | 4.19M | 1.54M | 6.46M | 4.74M |
| Days Payables Outstanding | - | 47.09K | 19.94K | 26.66K | 52.39 | 54.02 | - | - | 5.53K | - |
| Short-Term Debt | 3.14M | 30.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -4.39M | 0 | 0 | 0 | 0 | 0 | 0 | 8K | 2.78M | 0 |
| Current Ratio | 21.83x | 0.11x | 4.55x | 2.69x | 3.50x | 37.37x | 11.70x | 17.07x | 5.64x | 3.41x |
| Quick Ratio | 21.83x | 0.11x | 4.55x | 2.69x | 3.09x | 36.83x | 11.70x | 16.62x | 5.64x | 3.41x |
| Cash Conversion Cycle | - | - | - | - | 76.35 | 91.59 | - | - | - | - |
| Total Non-Current Liabilities | 0 | 70.53M | 11.86M | 3.45M | 1.4M | 1.21M | 37K | 331K | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 769K | 524K | 37K | 256K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 70.53M | 11.86M | 3.45M | 632K | 685K | 0 | 75K | 0 | 0 |
| Total Liabilities | 1.28M | 6.46M | 17.95M | 9.9M | 2.98M | 3.01M | 10.02M | 3.45M | 12.68M | 14.08M |
| Total Debt | 3.14M | 30.27M | 0 | 0 | 1M | 776K | 469K | 524K | 262K | 266K |
| Net Debt | -17.83M | 29.48M | -25.74M | -16.28M | -1.39M | -63.05M | -114.45M | -20.47M | -70.38M | -46.98M |
| Debt / Equity | 0.12x | - | - | - | 0.18x | 0.01x | 0.00x | 0.01x | 0.00x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1171.61x | -22.32x | -267.37x | -1618.47x | -151.13x | -88.36x | -1010.39x | -1051.17x | - | - |
| Total Equity | 26.87M | -100.23M | 11.12M | 9.18M | 5.72M | 67.41M | 107.89M | 54.64M | 60.14M | 35.05M |
| Equity Growth % | -0.42% | -4.73% | 1.11% | -0.17% | -0.38% | 10.78% | 0.6% | -0.49% | 0.1% | -0.42% |
| Book Value per Share | 15.75 | -106.71 | 12.10 | 6.37 | 2.53 | 11.36 | 12.57 | 4.83 | 2.94 | 0.93 |
| Total Shareholders' Equity | 26.87M | -100.23M | 11.12M | 9.18M | 5.72M | 67.41M | 107.89M | 54.64M | 60.14M | 35.05M |
| Common Stock | 47K | 0 | 12K | 15K | 69K | 142K | 88K | 142K | 26K | 38K |
| Retained Earnings | -89.3M | -100.67M | -130.4M | -153.53M | -87.94M | -91.33M | -263.57M | -105.93M | -399.58M | -467.37M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -498K | 294K | -268K | 302K | 0 | 0 | -267K | 0 | 106K | -120K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -19.58M | -25.34M | -22.14M | -26.03M | -26.9M | -25.96M | -35.16M | -49.04M | -43.75M | -60.3M |
| Operating CF Margin % | - | - | - | - | -2.78% | -2.58% | -23.44% | - | - | - |
| Operating CF Growth % | -0.09% | -0.29% | 0.13% | -0.18% | -0.03% | 0.04% | -0.35% | -0.4% | 0.11% | -0.38% |
| Net Income | -21.1M | -25.63M | -29.73M | -23.14M | -32.9M | -27.51M | -40.59M | -54.6M | -81.41M | -67.56M |
| Depreciation & Amortization | 474K | 25K | 48K | 49K | 47K | 34K | 29K | 16K | 15K | 5K |
| Stock-Based Compensation | 1.72M | 45K | 5.6M | 3.47M | 3.89M | 2.62M | 3.48M | 5.18M | 5.13M | 5.5M |
| Deferred Taxes | 370K | 0 | -158K | 20K | 0 | 0 | 379K | 0 | 0 | 0 |
| Other Non-Cash Items | 14K | 1.23M | -194K | -7.3M | 729K | -104K | 527K | 1.01M | 30.01M | 457K |
| Working Capital Changes | -1.05M | -1.01M | 2.29M | 871K | 1.33M | -990K | 1.01M | -651K | 2.51M | 1.29M |
| Change in Receivables | 0 | -3.05M | 1.46M | 780K | 643K | 117K | -1.16M | -1.01M | 1.3M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 1.16M | 0 | 0 | 0 |
| Change in Payables | 0 | 2.27M | 1.09M | 368K | 0 | 0 | 3.9M | 0 | 712K | 902K |
| Cash from Investing | 29.69M | -144K | -64K | 0 | -85K | 25K | 0 | 0 | 48.97M | 0 |
| Capital Expenditures | -12K | -144K | -64K | 0 | -100K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | 0.01% | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 9K | 0 | -64K | 0 | 15K | 25K | 0 | 0 | -1.39M | 0 |
| Cash from Financing | 16K | 25.62M | 47.76M | 15.91M | 14.82M | 74M | 98.03M | -210K | -30K | 37.18M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -8.25M | -282K | -2.15M | 872K | -437K | -1.51M | 813K | -210K | -1K | -2.81M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -19.59M | -25.48M | -22.2M | -26.03M | -27M | -25.96M | -35.16M | -49.04M | -43.75M | -60.3M |
| FCF Margin % | - | - | - | - | -2.79% | -2.58% | -23.44% | - | - | - |
| FCF Growth % | -0.07% | -0.3% | 0.13% | -0.17% | -0.04% | 0.04% | -0.35% | -0.4% | 0.11% | -0.38% |
| FCF per Share | -11.49 | -27.13 | -24.16 | -18.06 | -11.96 | -4.38 | -4.10 | -4.33 | -2.14 | -1.61 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.99x | 0.74x | 1.13x | 7.81x | 7.66x | 0.87x | 0.90x | 0.54x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -57.75% | - | -267.4% | -228.05% | -46.26% | -9.26% | -46.31% | -67.18% | -141.86% | -141.94% |
| Return on Invested Capital (ROIC) | -71.27% | - | - | - | - | -59.48% | - | -308.35% | -545.53% | - |
| Gross Margin | - | - | - | - | 52.93% | 50.94% | 100% | - | - | - |
| Net Margin | - | - | - | - | -35.6% | -33.69% | -2705.8% | - | - | - |
| Debt / Equity | 0.12x | - | - | - | 0.18x | 0.01x | 0.00x | 0.01x | 0.00x | 0.01x |
| Interest Coverage | -1171.61x | -22.32x | -267.37x | -1618.47x | -151.13x | -88.36x | -1010.39x | -1051.17x | - | - |
| FCF Conversion | 0.93x | 0.99x | 0.74x | 1.13x | 7.81x | 7.66x | 0.87x | 0.90x | 0.54x | 0.89x |
| Revenue Growth | - | - | - | - | - | 3.85% | -85.08% | -100% | - | - |
| 2020 | 2021 | |
|---|---|---|
| License | 1.5M | 1.5M |
| License Growth | - | 0.00% |
| Royalty | - | - |
| Royalty Growth | - | - |
Cypherpunk Technologies Inc. (CYPH) reported $0.4M in revenue for fiscal year 2024.
Cypherpunk Technologies Inc. (CYPH) grew revenue by 0.0% over the past year. Growth has been modest.
Cypherpunk Technologies Inc. (CYPH) reported a net loss of $98.2M for fiscal year 2024.
Cypherpunk Technologies Inc. (CYPH) has a return on equity (ROE) of -141.9%. Negative ROE indicates the company is unprofitable.
Cypherpunk Technologies Inc. (CYPH) had negative free cash flow of $62.8M in fiscal year 2024, likely due to heavy capital investments.